Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03213834 · ClinicalTrials.gov registry record · Phase 4
Fibrinolytic Therapy Versus Medical Thoracoscopy
A Phase 4 study of Pleural Diseases, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03213834 is a Phase 4 study of Pleural Diseases that has completed, run by University of Florida. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03213834, a Phase 4 study of Pleural Diseases, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: medical thoracoscopy as compared to instillation of intrapleural tissue plasminogen activator (TPA) and human recombinant deoxyribonuclease (DNase) for the management of complicated pleural infections in adults as defined as complicated parapneumonic effusions or pleural empyema.
Conditions Studied
Interventions
- DRUG tPA
- PROCEDURE Chest thoracoscopy
- PROCEDURE Chest fibrinolytic therapy
- DRUG DNase
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-09-14 |
| Est. Completion | 2020-02-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03213834
The ClinicalTrials.gov registry entry for NCT03213834 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pleural Diseases appearing as the primary indexed condition, and to 4 interventions - of which tPA is the first listed.
NCT03213834 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03213834 about?
NCT03213834 is a clinical study titled "Fibrinolytic Therapy Versus Medical Thoracoscopy". The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: medical thoracoscopy as compared to instillation of intrapleural tissue plasminogen activator (TPA) and human recombinant deoxyribonuclease (DNase) for the management...
What is the current status of trial NCT03213834?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2017-09-14. Estimated completion is 2020-02-04.
What conditions does trial NCT03213834 study?
This clinical trial studies the following conditions: Pleural Diseases.
What interventions are being tested in trial NCT03213834?
The interventions under investigation include: tPA (DRUG), Chest thoracoscopy (PROCEDURE), Chest fibrinolytic therapy (PROCEDURE), DNase (DRUG).
Who is sponsoring clinical trial NCT03213834?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03213834 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.